American Society for Clinical Pathology - Usefulness of Cytokeratin 5/6 and AMACR Applied as Double Sequential Immunostains for Diagnostic Assessment of Problematic Prostate Specimens

Usefulness of Cytokeratin 5/6 and AMACR Applied as Double Sequential Immunostains for Diagnostic Assessment of Problematic Prostate Specimens

Kiril Trpkov, MD, FRCPC
Department of Pathology and Laboratory Medicine, Calgary Laboratory Services and University of Calgary, Calgary, Canada

Joanna Bartczak-McKay, BSc, MLT
Department of Pathology and Laboratory Medicine, Calgary Laboratory Services and University of Calgary, Calgary, Canada

Asli Yilmaz, MD, FRCPC
Department of Pathology and Laboratory Medicine, Calgary Laboratory Services and University of Calgary, Calgary, Canada

Keywords: Prostate carcinoma; Immunohistochemistry; Cytokeratin 5/6; α-Methylacyl-CoA racemase; AMACR; P504S; Double immunohistochemistry

Upon completion of this activity, you will be able to:

discuss the role of immunohistochemistry in the routine assessment of prostate specimens.
list the common scenarios in which immunohistochemistry is useful in evaluating problematic prostate foci.
describe the advantages of using double immunostaining for cytokeratin 5/6 and α-methylacyl coenzyme A racemase for the evaluation of problematic prostatic specimens.

This activity meets MOC Part II Lifelong Learning requirements. A self-assessment option is available for pathologists attending this program to earn SAM credits for Maintenance of Certification, Part II Self-Assessment Modules (MOC-SAM) for part of the course.

List Price

$20.00

Member Price

$15.00

From:
Email:
To:
Email:
Subject:
Message: